Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer
Haiyang Chen(Okayama University), Shinichi Toyooka(Okayama University)
Cited by 28
Related Papers
Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features
|Scientific Reports|2017|60
Anti-Cancer Effects of REIC/Dkk-3-encoding Adenoviral Vector for the Treatment of Non-small Cell Lung Cancer
|PLoS ONE|2014|27
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
|Oncogenesis|2018|27
Anti‑tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations
|Oncology Letters|2019|24